Guo R - Search Results

1

MicroRNA-1 inhibits tumorigenicity of esophageal squamous cell carcinoma and enhances sensitivity to gefitinib.

Yu Q, Liu Y, Wen C, Zhao Y, Jin S, Hu Y, Wang F, Chen L, Zhang B, Wang W, Zhu Q, Guo R. Yu Q, et al. Among authors: guo r. Oncol Lett. 2018 Jan;15(1):963-971. doi: 10.3892/ol.2017.7378. Epub 2017 Nov 9. Oncol Lett. 2018. PMID: 29399158 Free PMC article.

2

Tamoxifen inhibits proliferation and induces apoptosis in human hepatocellular carcinoma cell line HepG2 via down-regulation of survivin expression.

Guo R, Huang Z, Shu Y, Jin S, Ge H. Guo R, et al. Biomed Pharmacother. 2009 Jun;63(5):375-9. doi: 10.1016/j.biopha.2008.09.010. Epub 2008 Oct 23. Biomed Pharmacother. 2009. PMID: 18993026

3

[Insulin/PI3K signalling pathway regulates the expression of survivin in liver cancer HepG2 cells].

Guo RH, Jin SD, Cai J, Huang ZH, Shu YQ. Guo RH, et al. Zhonghua Zhong Liu Za Zhi. 2008 Oct;30(10):745-8. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19173802 Chinese.

4

Phase II study of weekly irinotecan plus cisplatin in patients with previously untreated extensive-stage extrapulmonary small cell carcinoma.

Jin S, Wang T, Chen X, Xu B, Sun J, Guo R, Shu Y. Jin S, et al. Among authors: guo r. Onkologie. 2011;34(7):378-81. doi: 10.1159/000329609. Epub 2011 Jun 24. Onkologie. 2011. PMID: 21734424 Clinical Trial.

5

[Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC)].

Liu YQ, Guo RH, Liu LK, Gao W, Zhu CJ, Wei J, Shu YQ. Liu YQ, et al. Zhonghua Zhong Liu Za Zhi. 2011 Jun;33(6):426-30. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 21875482 Chinese.

6

c-Met upregulates aquaporin 3 expression in human gastric carcinoma cells via the ERK signalling pathway.

Wang J, Gui Z, Deng L, Sun M, Guo R, Zhang W, Shen L. Wang J, et al. Among authors: guo r. Cancer Lett. 2012 Jun 1;319(1):109-17. doi: 10.1016/j.canlet.2011.12.040. Epub 2012 Jan 17. Cancer Lett. 2012. PMID: 22261330

7

Clinicopathological significance of lymphatic vessel density marked by D2-40 and E-cadherin expression in non-small-cell lung cancer.

Jin S, Zhu W, Shi Q, Zhang Z, Guo R. Jin S, et al. Among authors: guo r. Med Oncol. 2012 Dec;29(5):3157-61. doi: 10.1007/s12032-012-0229-5. Epub 2012 Apr 18. Med Oncol. 2012. PMID: 22528515

8

Recombinant human endostatin (endostar) decreased recurrent ascites, pleural fluid and ascitic VEGF in a case of advanced mesothelioma.

Chen X, Liu Y, Yin Y, Jin S, Ping G, Røe OD, Yan K, Shu Y, Guo R. Chen X, et al. Among authors: guo r. J Chemother. 2012 Aug;24(4):231-6. doi: 10.1179/1973947812Y.0000000023. J Chemother. 2012. PMID: 23040690

9

Gefitinib or erlotinib as maintenance therapy in patients with advanced stage non-small cell lung cancer: a systematic review.

Chen X, Liu Y, Røe OD, Qian Y, Guo R, Zhu L, Yin Y, Shu Y. Chen X, et al. Among authors: guo r. PLoS One. 2013;8(3):e59314. doi: 10.1371/journal.pone.0059314. Epub 2013 Mar 21. PLoS One. 2013. PMID: 23555654 Free PMC article. Review.

10

Upregulation of the eIF4E signaling pathway contributes to the progression of gastric cancer, and targeting eIF4E by perifosine inhibits cell growth.

Liang S, Guo R, Zhang Z, Liu D, Xu H, Xu Z, Wang X, Yang L. Liang S, et al. Among authors: guo r. Oncol Rep. 2013 Jun;29(6):2422-30. doi: 10.3892/or.2013.2397. Epub 2013 Apr 9. Oncol Rep. 2013. PMID: 23588929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,781 results

Search Page

Filters